Companies / Santa Cruz Biotechnology / SIRP-α/β (A-1) Alexa Fluor® 546
Santa Cruz Biotechnology

SIRP-α/β (A-1) Alexa Fluor® 546 | Santa Cruz Biotechnology

mouse monoclonal IgG1; SIRP-α/β Antibody (A-1) is an IgG1 κ mouse monoclonal SIRP- alpha / beta antibody (also designated SIRP alpha/beta antibody or SIRPa/b antibody) that detects the SIRP- alpha / beta protein of human origin by WB, IP, IF, IHC(P) and ELISA. SIRP-α/β Antibody (A-1) is available as both the non-conjugated anti-SIRP- alpha / beta antibody form, as well as multiple conjugated forms of anti-SIRP- alpha / beta antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. SIRPs (signal-regulatory proteins) are a family of transmembrane glycoproteins that were identified by their association with the Src homology 2 domain-containing protein-tyrosine phosphatase SHP-2 in response to insulin. The SIRP family negatively regulates the PI 3-kinase pathway, which may diminish EGFR-mediated motility and survival phenotypes that contribute to transformation of certain cell types. SIRP-α1 is a transmembrane protein which contains an extracellular portion with three immunoglobulin-like structures and a cytoplasmic region with four potential tyrosine phosphorylation sites. SIRP-α (also known as SIRP-α1, SIRP-α2 or SIRP-α3) is a substrate for activated receptor tyrosine kinases. In its tyrosine phosphorylated form, SIRP-α binds to SH-PTP2 through SH2 interactions and acts as an SH-PTP2 substrate. SIRP-α has been shown to have negative regulatory effects on cellular responses induced by growth factors, oncogenes and insulin. SIRP-β1 shares extensive sequence homology with SIRP-α in its extracellular portion but lacks the cytoplasmic portion. SIRP-γ, originally designated SIRP-β2 (SIRP-B2, CD172g) has unique characteristics from both the α and β versions. SIRP-γ is expressed on the majority of T cells and a proportion of B cells. CD47 associates with SIRP-γ, and this interaction signals unidirectionally only.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.

  • See More